Clinical Trial Update: Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 trial update on anastrozole for chemoprevention in postmenopausal women with ductal carcinoma in situ (DCIS); trial completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ductal Carcinoma in Situ

Drugs mentioned

• Anastrozole (Anastrozole)

Snippet

Sponsor: Rita Sanghvi, Mehta | Conditions: DCIS | Phase 2 | Status: COMPLETED | Results posted: 2021-05-11